| Darryn Band, MD | |
|
10313 Georgia Ave, Ste 202, Silver Spring, MD 20902-5006 | |
| (301) 681-9101 | |
| (301) 681-3525 |
| Full Name | Darryn Band |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 35 Years |
| Location | 10313 Georgia Ave, Silver Spring, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811978935 | NPI | - | NPPES |
| 651921100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D0044797 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Womens Care Llc | 4880582741 | 248 |
News Archive
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
Researchers at UT Southwestern Medical Center at Dallas have successfully tested the first gene therapy for skin cancer, using a mouse model for the disease xeroderma pigmentosum, or XP.
A 2010 GOOD DESIGN Award has been awarded to Novo Nordisk for NovoPen Echo, the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives.
Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study to be presented to the 8th European Breast Cancer Conference.
› Verified 3 days ago
| Entity Name | Capital Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20040315000188 |
News Archive
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
Researchers at UT Southwestern Medical Center at Dallas have successfully tested the first gene therapy for skin cancer, using a mouse model for the disease xeroderma pigmentosum, or XP.
A 2010 GOOD DESIGN Award has been awarded to Novo Nordisk for NovoPen Echo, the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives.
Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study to be presented to the 8th European Breast Cancer Conference.
› Verified 3 days ago
| Entity Name | Professional Services Of Holy Cross |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487692828 PECOS PAC ID: 3779516992 Enrollment ID: O20050916000745 |
News Archive
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
Researchers at UT Southwestern Medical Center at Dallas have successfully tested the first gene therapy for skin cancer, using a mouse model for the disease xeroderma pigmentosum, or XP.
A 2010 GOOD DESIGN Award has been awarded to Novo Nordisk for NovoPen Echo, the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives.
Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study to be presented to the 8th European Breast Cancer Conference.
› Verified 3 days ago
| Entity Name | Maryland Physicians Edge Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972922920 PECOS PAC ID: 5890913503 Enrollment ID: O20140821001233 |
News Archive
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
Researchers at UT Southwestern Medical Center at Dallas have successfully tested the first gene therapy for skin cancer, using a mouse model for the disease xeroderma pigmentosum, or XP.
A 2010 GOOD DESIGN Award has been awarded to Novo Nordisk for NovoPen Echo, the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives.
Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study to be presented to the 8th European Breast Cancer Conference.
› Verified 3 days ago
| Entity Name | Obhg Maryland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851657894 PECOS PAC ID: 3577728211 Enrollment ID: O20220103000291 |
News Archive
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
Researchers at UT Southwestern Medical Center at Dallas have successfully tested the first gene therapy for skin cancer, using a mouse model for the disease xeroderma pigmentosum, or XP.
A 2010 GOOD DESIGN Award has been awarded to Novo Nordisk for NovoPen Echo, the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives.
Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study to be presented to the 8th European Breast Cancer Conference.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darryn Band, MD 8110 Maple Lawn Blvd Ste 235, Fulton, MD 20759-2694 Ph: (301) 340-8339 | Darryn Band, MD 10313 Georgia Ave, Ste 202, Silver Spring, MD 20902-5006 Ph: (301) 681-9101 |
News Archive
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
Researchers at UT Southwestern Medical Center at Dallas have successfully tested the first gene therapy for skin cancer, using a mouse model for the disease xeroderma pigmentosum, or XP.
A 2010 GOOD DESIGN Award has been awarded to Novo Nordisk for NovoPen Echo, the latest innovation in pen development - designed specifically with the needs of children in mind. Judging is made based on product design which is new, visionary and innovative and that may enrich people's lives.
Women who are overweight or obese when they are diagnosed with breast cancer are at higher risk of cancer recurrence or related death than are leaner women, according to a new study to be presented to the 8th European Breast Cancer Conference.
› Verified 3 days ago
Dr. Allan Robert Handysides, MB, CHB, FRCPC, FRCS Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 12501 Old Columbia Pike, Silver Spring, MD 20904 Phone: 301-680-6702 Fax: 301-680-6707 | |
Brad Howard Norman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Forest Glen Rd, Ste 525, Silver Spring, MD 20910 Phone: 301-593-8101 Fax: 301-593-1537 | |
Dr. Sweta Rohit Patel, D.O Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1400 Forest Glen Rd, Suite 500, Silver Spring, MD 20910 Phone: 301-681-6772 Fax: 301-681-2773 | |
Sontaek Theodore Lee, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11217 Lockwood Dr, Silver Spring, MD 20901 Phone: 301-681-7712 Fax: 301-681-7734 | |
Peggy Jb Scurry, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 8484 Georgia Ave, Silver Spring, Silver Spring, MD 20910 Phone: 301-495-7420 Fax: 301-495-7423 | |
Ms. Wendy P. Dooley, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1716 Loft Way, Silver Spring, MD 20904 Phone: 240-460-7867 | |
Mrs. Tiffany Chanel Wilson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Forest Glen Rd, Suite 500, Silver Spring, MD 20910 Phone: 301-681-6772 Fax: 301-681-2773 |